Overview
Oxiconazole is an antifungal agent that is commonly found in topical formulations. It is marketed under the brand names Oxistat and Oxistat, and is used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm.
Indication
For treatment of dermal fungal infection.
Associated Conditions
- Fungal skin infection
- Pityriasis versicolor
- Tinea Corporis
- Tinea Cruris
- Tinea Pedis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2019/01/30 | Phase 1 | Completed | Minia University | ||
2012/01/27 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | 62559-285 | TOPICAL | 10 mg in 1 mL | 8/23/2022 | |
| PharmaDerm a division of Fougera Pharmaceuticals Inc. | 10337-358 | TOPICAL | 10 mg in 1 g | 1/15/2012 | |
| PharmaDerm a division of Fougera Pharmaceuticals Inc. | 10337-359 | TOPICAL | 10 mg in 1 mL | 1/15/2012 | |
| Taro Pharmaceuticals U.S.A., Inc. | 51672-1359 | TOPICAL | 10 mg in 1 g | 12/11/2019 | |
| Rebel Distributors Corp. | 21695-459 | TOPICAL | 30 mg in 1 g | 10/29/2009 | |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 0168-0358 | TOPICAL | 10 mg in 1 g | 2/13/2019 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| SALONGO 10 mg/g CREMA | Meda Pharma S.L. | 59854 | CREMA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.